Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting

Carcinogenesis

Volumn 35, Issue 8, 2014, Pages 1823-1829

  Wu, De Wei ^a   Chuang, Chun Yi ^b,c   Lin, Wea Long ^b,c   Sung, Wen Wei ^b   Cheng, Ya Wen ^a   Lee, Huei ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

miR 218; Oral cancer; OS; Paxillin; RFS

Indexed keywords

MICRORNA; MICRORNA 218; PARAFFIN; PAXILLIN; UNCLASSIFIED DRUG; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; MESSENGER RNA; MIRN128 MICRORNA, HUMAN; ONCOPROTEIN; PXN PROTEIN, HUMAN; REPRESSOR PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA CELL; CELL INVASION; CELL INVASION ASSAY; COLONY FORMATION; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL CAVITY SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; CANCER STAGING; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; ENZYME IMMUNOASSAY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR RECURRENCE; VIROLOGY;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PAXILLIN; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84905717304     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu102     Document Type: Article

References (34)

1. Jemal, A., et al. (2011) Global cancer statistics. CA Cancer J Clin, 61, 69-90.
2. Gupta, G.P., et al. (2006) Cancer metastasis: building a framework. Cell, 127, 679-95.
3. Chuang, C.Y., et al. (2012) Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas. PLoS One, 7, e47541.
4. Chaturvedi, A.K., et al. (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol, 26, 612-9.
5. Brown, M.C., et al. (2004) Paxillin: adapting to change. Physiol Rev, 84, 1315-39.
6. Webb, D.J., et al. (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol, 6, 154-61.
7. Brown, M.C., et al. (2005) Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Mol Biol Cell, 16, 4316-28.
8. Deakin, N.O., et al. (2011) Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell, 22, 327-41.
9. Tabassam, F.H., et al. (2011) Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am J Physiol Gastrointest Liver Physiol, 301, G601-11.
10. Li, D., et al. (2009) Fibronectin promotes tyrosine phosphorylation of paxillin and cell invasiveness in the gastric cancer cell line AGS. Tumori, 95, 769-79.
11. Shi, J., et al. (2010) Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma. J Oral Pathol Med, 39, 548-51.
12. Chen, D.L., et al. (2013) Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis, 34, 803-11.
13. Wu, D.W., et al. (2010) Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res, 70, 10392-401.
14. Wu, D.W., et al. (2013) Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression. Oncogene.
15. Martinez, I., et al. (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene, 27,2575-82.
16. Sanjiv, K., et al. (2012) The novel DNA alkylating agent BO-1090 suppresses the growth of human oral cavity cancer in xenografted and orthotopic mouse models. Int J Cancer, 130, 1440-50.
17. Lee, S.S., et al. (2008) Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma. J Formos Med Assoc, 107, 355-63.
18. Tie, J., et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet, 6, e1000879.
19. Schembri, F., et al. (2009) MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A, 106, 2319-24.
20. Gao, C., et al. (2010) Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer, 116, 41-9.
21. McCormack, S.J., et al. (1997) Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene, 15, 265-74.
22. Zhu, C., et al. (2012) The relationship between oral squamous cell carcinomaand human papillomavirus: a meta-analysis of a Chinese population (1994-2011). PLoS One, 7, e36294.
23. Laco, J., et al. (2011) The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases. Virchows Arch, 458, 179-87.
24. Lee, L.A., et al. (2012) Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One, 7, e40767.
25. Benson, E., et al. (2013) The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol.
26. Conway, W.C., et al. (2006) Paxillin modulates squamous cancer cell adhesion and is important in pressure-augmented adhesion. J Cell Biochem, 98, 1507-16.
27. Huang, Y., et al. (2008) Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes. Cell Cycle, 7, 1613-22.
28. Fakhry, C., et al. (2013) Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol, 49, 863-71.
29. Fakhry, C., et al. (2006) Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol, 24, 2606-11.
30. Walboomers, J.M., et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
31. Scheffner, M., et al. (1992) Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J Virol, 66, 5100-5.
32. Wade, R., et al. (2008) Transformation by bovine papillomavirus type 1 E6 requires paxillin. J Virol, 82, 5962-6.
33. Tong, X., et al. (1997) The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem, 272, 33373-6.
34. Tong, X., et al. (1997) The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U S A, 94, 4412-7.